,"Authors: Williams, Richard O.; Williams, Richards O.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 22 (Of the 56 documents considered for the h-Index, 22 have been cited at least 22 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,2113,263,220,483,125,2721
2009,"Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis","Criado G., Simelyte E., Inglis J.J., Essex D., Williams R.O.",00043591,"Arthritis and Rheumatism",60, 5,0,0,0,0,0,0
2009,"Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis","Andreakos E., Gaus H., Bennett C.F., Williams R.O., Sideras P., Panzner S., Rauchhaus U., Stavropoulos A., Endert G., Wendisch V., Benahmed A.S., Giaglis S., Karras J., Lee S.",00043591,"Arthritis and Rheumatism",60, 4,0,0,0,0,1,1
2008,"Reduction of cPLA2? overexpression: An efficient anti-inflammatory therapy for collagen-induced arthritis","Raichel L., Berger S., Hadad N., Kachko L., Karter M., Szaingurten-Solodkin I., Williams R.O., Feldmann M., Levy R.",00142980,"European Journal of Immunology",38, 10,0,0,0,0,0,0
2008,"Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells","Notley C.A., Inglis J.J., Alzabin S., McCann F.E., McNamee K.E., Williams R.O.",00221007,"Journal of Experimental Medicine",205, 11,0,0,0,0,7,7
2008,"Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system","Inglis J.J., McNamee K.E., Chia S.-L., Essex D., Feldmann M., Williams R.O., Hunt S.P., Vincent T.",00043591,"Arthritis and Rheumatism",58, 10,0,0,0,0,2,2
2008,"Plasmid DNA as a safe gene delivery vehicle for treatment of chronic inflammatory disease","Clanchy F.I.L., Williams R.O.",14712598,"Expert Opinion on Biological Therapy",8, 10,0,0,0,0,0,0
2008,"Novel approaches to the therapy of rheumatoid arthritis based on an understanding of disease mechanisms","McCann F.E., Williams R.O.",18715222,"Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry",8, 3,0,0,0,0,1,1
2008,"Paradoxical effects of tumour necrosis factor-? in adjuvant-induced arthritis","Williams R.O.",14786354,"Arthritis Research and Therapy",10, 3,0,0,1,1,0,1
2008,"Protocol for the induction of arthritis in C57BL/6 mice","Inglis J.J., Simelyte E., McCann F.E., Criado G., Williams R.O.",17542189,"Nature Protocols",3, 4,0,0,0,0,2,2
2008,"CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis","Simelyte E., Criado G., Essex D., Uger R.A., Feldmann M., Williams R.O.",00043591,"Arthritis and Rheumatism",58, 4,0,0,1,1,2,3
2007,"Collagen-induced arthritis as a model of hyperalgesia: Functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade","Inglis J.J., Notley C.A., Essex D., Wilson A.W., Feldmann M., Anand P., Williams R.",00043591,"Arthritis and Rheumatism",56, 12,0,0,3,3,6,9
2007,"Collagen-induced arthritis in mice.","Williams R.O.",15431894,"Methods in molecular medicine",136, ,0,0,3,3,5,8
2007,"Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis [3]","Seymour M.W., Home D.M., Williams R.O., Allard S.A.",14620324,"Rheumatology",46, 11,0,0,0,0,2,2
2007,"Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen","Inglis J.J., Criado G., Medghalchi M., Andrews M., Sandison A., Feldmann M., Williams R.O.",14786354,"Arthritis Research and Therapy",9, 5,0,0,4,4,0,4
2007,"The anti-allergic drug, N -(3?,4?-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis","Inglis J.J., Criado G., Andrews M., Feldmann M., Williams R.O., Selley M.L.",14620324,"Rheumatology",46, 9,0,0,3,3,2,5
2007,"Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases","Williams R.O., Paleolog E., Feldmann M.",14714892,"Current Opinion in Pharmacology",7, 4,0,0,4,4,6,10
2006,"Pathogenesis and therapy of rheumatoid arthritis.","Williams R.O.",,"Ernst Schering Foundation symposium proceedings",1, ,0,0,0,0,0,0
2006,"Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-? expression in the joint","Marinova-Mutafchieva L., Gabay C., Funa K., Williams R.O.",00099104,"Clinical and Experimental Immunology",146, 2,0,1,1,2,1,3
2006,"Activation of NF-?B by the intracellular expression of NF-?B-inducing kinase acts as a powerful vaccine adjuvant","Andreakos E., Williams R.O., Wales J., Foxwell B.M., Feldmann M.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",103, 39,0,6,9,15,3,18
2005,"Anti-TNF therapy: Where have we got to in 2005?","Feldmann M., Brennan F.M., Foxwell B.M.J., Taylor P.C., Williams R.O., Maini R.N.",08968411,"Journal of Autoimmunity",25, ,7,18,13,31,7,45
2005,"Models of rheumatoid arthritis.","Williams R.O.",09476075,"Ernst Schering Research Foundation workshop.",, 50,2,1,3,4,0,6
2005,"Analysing the effect of novel therapies on cytokine expression in experimental arthritis","Williams R.O., Inglis J.J., Simelyte E., Criado G., Sumariwalla P.F.",09599673,"International Journal of Experimental Pathology",86, 5,1,0,2,2,0,3
2005,"Erratum: RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy (Proceedings of the National Academy of Sciences of the United States of America (December 28, 2004) 101, 52 (18081-18086))","Nedvetzki S., Turley E.A., Naor D., Gonen E., Assayag N., Reich R., Williams R.O., Thurmond R.L., Huang J.-F., Neudecker B.A., Wang F.-S.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",102, 4,0,0,0,0,0,0
2004,"RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy","Nedvetzki S., Turley E.A., Naor D., Gonen E., Assayag N., Reich R., Williams R.O., Thurmond R.L., Huang J.-F., Neudecker B.A., Wang F.-S.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",101, 52,8,6,13,19,7,34
2004,"Anti-TNF? therapy of rheumatoid arthritis: What can we learn about chronic disease?","Feldmann M., Brennan F.M., Paleolog E., Cope A., Taylor P., Williams R., Woody J., Maini R.N.",15282511,"Novartis Foundation Symposium",256, ,20,3,2,5,0,25
2004,"Tumour necrosis factor ? as a therapeutic target for immune-mediated inflammatory diseases","Taylor P.C., Williams R.O., Feldmann M.",09581669,"Current Opinion in Biotechnology",15, 6,14,7,4,11,1,26
2004,"Collagen-induced arthritis as a model for rheumatoid arthritis.","Williams R.O.",15431894,"Methods in molecular medicine",98, ,3,7,2,9,2,14
2004,"The transfer of a laboratory based hypothesis to a clinically useful therapy: The development of anti-TNF therapy of rheumatoid arthritis","Feldmann M., Brennan F.M., Williams R.O., Woody J.N., Maini R.N.",15216942,"Best Practice and Research: Clinical Rheumatology",18, 1,15,5,6,11,3,29
2004,"Impact of cAMP on the T-cell response to type II collagen","Ozegbe P., Foey A.D., Ahmed S., Williams R.O.",00192805,"Immunology",111, 1,5,2,0,2,0,7
2003,"Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.","Foey A.D., Field S., Ahmed S., Jain A., Feldmann M., Brennan F.M., Williams R.",14786362,"Arthritis research & therapy",5, 6,9,9,3,12,4,25
2003,"Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response","Mauri C., Feldmann M., Williams R.O.",00043591,"Arthritis and Rheumatism",48, 3,7,3,3,6,2,15
2002,"Cutting edge: A-kinase anchor proteins are involved in maintaining resting T cells in an inactive state","Williams R.O.",00221767,"Journal of Immunology",168, 11,9,1,1,2,2,13
2002,"Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis","Marinova-Mutafchieva L., Williams R.O., Funa K., Maini R.N., Zvaifler N.J.",00043591,"Arthritis and Rheumatism",46, 2,29,5,7,12,2,43
2002,"Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis","Williams R.O.",00043591,"Arthritis and Rheumatism",46, 1,11,4,1,5,0,16
2001,"Immunotherapy for rheumatoid arthritis","Taylor P.C., Williams R.O., Maini R.N.",09527915,"Current Opinion in Immunology",13, 5,40,4,4,8,3,51
2001,"Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies","Malfait A.-M., Williams R.O., Malik A.S., Maini R.N., Feldmann M.",00043591,"Arthritis and Rheumatism",44, 5,13,3,5,8,1,22
2001,"Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis","Gabay C., Marinova-Mutafchieva L., Williams R.O., Gigley J.P., Butler D.M., Feldmann M., Arend W.P.",00043591,"Arthritis and Rheumatism",44, 2,27,3,1,4,0,31
2000,"Evaluation of TNF-? and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-?/anti-CD4 therapy","Williams R.O., Marinova-Mutafchieva L., Feldmann M., Maini R.N.",00221767,"Journal of Immunology",165, 12,25,12,6,18,4,47
2000,"Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.","Taylor P.C., Williams R.O., Maini R.N.",14222132,"Current directions in autoimmunity",2, ,4,1,0,1,2,7
2000,"Cartilage destruction and bone erosion in arthritis: The role of tumour necrosis factor ?","Williams R.O., Feldmann M., Maini R.N.",00034967,"Annals of the Rheumatic Diseases",59, 1,25,5,3,8,1,34
2000,"Future prospects for anti-cytokine treatment","Feldmann M., Miotla J., Paleolog E., Williams R., Malfait A.-M., Taylor P., Brennan F.-M., Maini R.N.",00034967,"Annals of the Rheumatic Diseases",59, 1,9,1,2,3,1,13
2000,"A comparative study into the mechanisms of action of anti-tumor necrosis factor ?, anti-CD4, and combined anti-tumor necrosis factor ?/anti-CD4 treatment in early collagen-induced arthritis","Marinova-Mutafchieva L., Williams R.O., Mauri C., Mason L.J., Walmsley M.J., Taylor P.C., Feldmann M., Maini R.N.",00043591,"Arthritis and Rheumatism",43, 3,12,1,2,3,0,15
1999,"Combination therapy with DMARDs and biological agents in collagen- induced arthritis","Williams R.O., Malfait A.-M., Butler D.M., Walmsley M.J., Feldmann M., Maini R.N.",0392856X,"Clinical and Experimental Rheumatology",17, 6,6,0,1,1,0,7
1999,"CD44 involvement in experimental collagen-induced arthritis (CIA)","Nedvetzki S., Walmsley M., Alpert E., Williams R.O., Feldmann M., Naor D.",08968411,"Journal of Autoimmunity",13, 1,22,7,3,10,0,32
1999,"Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis","Quattrocchi E., Walmsley M., Browne K., Williams R.O., Marinova-Mutafchieva L., Buurman W., Butler D.M., Feldmann M.",00221767,"Journal of Immunology",163, 2,58,2,1,3,0,61
1999,"Amelioration of collagen-induced arthritis and suppression of interferon-? interleukin-12, and tumor necrosis factor ? production by interferon-? gene therapy","Triantaphyllopoulos K.A., Williams R.O., Tailor H., Chernajovsky Y.",00043591,"Arthritis and Rheumatism",42, 1,56,7,6,13,5,74
1998,"Rodent models of arthritis: Relevance for human disease","Williams R.O.",00099104,"Clinical and Experimental Immunology",114, 3,14,3,1,4,0,18
1998,"Combination therapy in mice: What can we learn that may be useful for understanding rheumatoid arthritis?","Williams R.O.",03444325,"Springer Seminars in Immunopathology",20, 1-2,3,0,0,0,0,3
1998,"Therapeutic actions of cyclosporine and anti-tumor necrosis factor ? in collagen-induced arthritis and the effect of combination therapy","Williams R.O., Mauri C., Mason L.J., Marinova-Mutafchieva L., Ross S.E., Feldmann M., Maini R.N.",00043591,"Arthritis and Rheumatism",41, 10,24,1,1,2,1,27
1997,"Suppression of TNF-? Expression, Inhibition of Th1 Activity, and Amelioration of Collagen-Induced Arthritis by Rolipram","Ross S.E., Williams R.O., Mason L.J., Mauri C., Marinova-Mutafchieva L., Malfait A.-M., Maini R.N., Feldmann M.",00221767,"Journal of Immunology",159, 12,73,7,1,8,1,82
1997,"Suppression of Collagen-Induced Arthritis by Continuous Administration of IL-4","Horsfall A.C., Butler D.M., Marinova L., Warden P.J., Williams R.O., Maini R.N., Feldmann M.",00221767,"Journal of Immunology",159, 11,76,4,3,7,2,85
1997,"TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis","Maini R.N., Elliott M., Brennan F.M., Williams R.O., Feldmann M.",09034641,"APMIS",105, 4,35,2,1,3,0,38
1997,"Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA)","Marinova-Mutafchieva L., Williams R.O., Mason L.J., Mauri C., Feldmann M., Maini R.N.",00099104,"Clinical and Experimental Immunology",107, 3,62,9,7,16,4,82
1996,"Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis","Mauri C., Williams R.O., Walmsley M., Feldmann M.",00142980,"European Journal of Immunology",26, 7,189,17,12,29,1,219
1996,"Anti-CD4 monoclonal antibodies suppress murine collagen-induced arthritis only at the time of primary immunisation","Williams R.O., Whyte A.",00088749,"Cellular Immunology",170, 2,11,1,2,3,0,14
1996,"Interleukin-10 inhibition of the progression of established collagen-induced arthritis","Walmsley M., Katsikis P.D., Abney E., Parry S., Williams R.O., Maini R.N., Feldmann M.",00043591,"Arthritis and Rheumatism",39, 3,173,17,6,23,3,199
1995,"TNF? is an effective therapeatic target for rheumatoid arthritis","Feldmann M., Brennan F.M., Elliott M.J., Williams R.O., Maini R.N.",00778923,"Annals of the New York Academy of Sciences",766, ,42,5,1,6,0,48
1995,"Cytokine expression and networks in rheumatoid arthritis: Rationale for anti-TNFOC antibody therapy and its mechanism of action","Feldmann M., Brennan P.M., Williams R.O., Elliott M.J., Maini R.N.",10787852,"Journal of Inflammation",47, 1-2,18,2,2,4,1,23
1995,"Monoclonal anti-TNF? antibody as a probe of pathogenesis and therapy of rheumatoid disease","Maini R.N., Elliott M.J., Brennan F.M., Williams R.O., Chu C.Q., Paleolog E., Charles P.J., Taylor P.C., Feldmann M.",01052896,"Immunological Reviews",, 144,121,4,2,6,2,129
1995,"Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4","Williams R.O., Ghrayeb J., Feldmann M., Maini R.N.",00192805,"Immunology",84, 3,64,7,5,12,1,77
1994,"Targeting TNF? for the therapy of rheumatoid arthritis","Maini R.N., Elliott M., Brennan F.M., Williams R.O., Feldmann M.",0392856X,"Clinical and Experimental Rheumatology",12, 11,16,0,1,1,0,17
1994,"High levels of anti-type II collagen IgG in West African patients with rheumatoid arthritis","Adebajo A.O., Williams R.O., Williams D.G., Hazleman B.L., Maini R.N.",0315162X,"Journal of Rheumatology",21, 12,0,0,0,0,0,0
1994,"Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis","Williams R.O., Mason L.J., Feldmann M., Maini R.N.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",91, 7,127,5,6,11,4,142
1993,"Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma","Williams R.O., Williams D.G., Feldmann M., Maini R.N.",00099104,"Clinical and Experimental Immunology",92, 2,26,4,1,5,1,32
1993,"TNF-? in rheumatoid arthritis and prospects of anti-TNF therapy","Maini R.N., Brennan F.M., Williams R., Chu C.Q., Cope A.P., Gibbons D., Elliott M., Feldmann M.",0392856X,"Clinical and Experimental Rheumatology",11, 8,35,2,2,4,0,39
1992,"Evaluation of the role of cytokines in autoimmune disease: The importance of TNF? in rheumatoid arthritis","Feldmann M., Brennan F.M., Williams R.O., Cope A.P., Gibbons D.L., Katsikis P.D., Maini R.N.",13596101,"Cytokine and Growth Factor Reviews",4, 3,24,2,3,5,1,30
1992,"Anti-tumor necrosis factor ameliorates joint disease in murine collagen- induced arthritis","Williams R.O., Feldmann M., Maini R.N.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",89, 20,477,43,36,79,14,570
1992,"Successful transfer of collagen-induced arthritis to severe combined immunodeficient (SCID) mice","Williams R.O., Plater-Zyberk C., Williams D.G., Maini R.N.",00099104,"Clinical and Experimental Immunology",88, 3,17,0,1,1,1,19
1992,"Anti-type II collagen ELISA. Increased disease specificity following removal of anionic contaminants from salt-fractionated type II collagen","Williams R.O., Williams D.G., Maini R.N.",00221759,"Journal of Immunological Methods",147, 1,14,1,1,2,0,16
1991,"The immune response to autoantigens and viruses in rheumatic disease.","Venables P.J., Williams D.G., Horsfall A.C., Williams R.O., Stocks M.R., Maini R.N.",02637103,"British Journal of Rheumatology",30, ,2,0,0,0,0,2
1989,"A comparison of anti-type II collagen antibody titres and isotype profiles in pregnant and virgin DBA/1 mice with collagen-induced arthritis","Williams R.O., Whyte A.",01650378,"Journal of Reproductive Immunology",15, 3,0,0,1,1,0,1
1989,"Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes","Williams R.O., Whyte A., Waldmann H.",08916934,"Autoimmunity",4, 4,4,2,0,2,1,7
1988,"Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis","Whyte A., Williams R.O.",00043591,"Arthritis and Rheumatism",31, 7,29,1,1,2,0,31
